Patent · US Active

Automated system for controlling the blood sugar of a patient

US12383672B2 · kind B2 · utility

0Cited by

3References

7Claims

0Family size

Assignee

COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES · FR

Inventors

Hector-Manuel Romero Ugalde · Grenoble, FR
Eléonore Maeva Doron · Grenoble, FR
Stéphane Bonnet · Seyssinet-Pariset, FR
Romain Blanc · Grenoble, FR
Chantal Simon · L'Essart Mador, FR
Mael Garnotel · Pierre-Bénite, FR

Key dates

Filing date	Jun 27, 2019
Grant date	Aug 12, 2025
Priority date	—
Expiry date	Aug 13, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M2230/63
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

An automated system for controlling a patient's blood glucose, including a processing and control unit configured to predict the future trend of the patient's blood glucose based on a physiological model, wherein the physiological model includes a differential equation system describing the time variation of a plurality of state variables, and wherein at least one of the equations of the system takes as an input a variable EE(t) representative of the time variation of the patient's energy expenditure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.